SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001373451-12-000003
Filing Date
2012-05-09
Accepted
2012-05-09 14:29:24
Documents
1
Period of Report
2012-01-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 4870
  Complete submission text file 0001373451-12-000003.txt   6447
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4225 EXECUTIVE SQUARE SUITE 485 LA JOLLA CA 92037
Business Address
Schupp Joachim PH (Reporting) CIK: 0001373451 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-52998 | Film No.: 12825102